Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. 2003

Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
Department of Neurosurgery, National Defense Medical College, Tokorozawa, Japan. ndmcsf@aol.com

BACKGROUND The authors recently reported that nuclear accumulation of basic fibroblast growth factor (bFGF) demonstrated a significant correlation with recurrence of pituitary adenomas. The current study sought to determine whether nuclear bFGF accumulation was a predictor of survival in patients with astrocytic tumors. METHODS The authors examined 52 patients with primary astrocytic tumors. Immunohistochemical assays for bFGF, fibroblast growth factor receptor 1 (FGFR1), and proliferating cell nuclear antigen were performed. Immunoreactivity of bFGF in nuclei was recorded in terms of the bFGF nuclear index (NI), which was calculated as the percentage of tumor cells with nuclear immunoreactivity. Western blot analysis of bFGF in nuclear fractions was performed. RESULTS The bFGF NI had a mean value of 35.1% and was < 30% (low NI) in 27 patients and >or= 30% (high NI) in 25 patients. In all cases, FGFR1 immunoreactivity was observed in the cytoplasm but not in the nucleus. Western blot analysis indicated that the nuclear fractions from tumor specimens with high NI contained high-molecular-weight bFGF. Univariate analyses showed that age, tumor histology, gender, and bFGF NI were significantly correlated with patient survival. Multivariate analyses demonstrated that NI had the greatest influence (P = 0.0073) on survival rate, compared with age (P = 0.0083) and gender (P = 0.0492). Compared with low NI, high NI was associated with a relative risk of 3.292. CONCLUSIONS The findings of the current study suggest that bFGF NI may be a useful predictor of survival in patients with astrocytic tumors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D005260 Female Females
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001254 Astrocytoma Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082) Astrocytoma, Subependymal Giant Cell,Glioma, Astrocytic,Oligoastrocytoma, Mixed,Pleomorphic Xanthoastrocytomas,Anaplastic Astrocytoma,Astrocytoma, Grade I,Astrocytoma, Grade II,Astrocytoma, Grade III,Astrocytoma, Protoplasmic,Astroglioma,Cerebral Astrocytoma,Childhood Cerebral Astrocytoma,Fibrillary Astrocytoma,Gemistocytic Astrocytoma,Intracranial Astrocytoma,Juvenile Pilocytic Astrocytoma,Pilocytic Astrocytoma,Subependymal Giant Cell Astrocytoma,Anaplastic Astrocytomas,Astrocytic Glioma,Astrocytic Gliomas,Astrocytoma, Anaplastic,Astrocytoma, Cerebral,Astrocytoma, Childhood Cerebral,Astrocytoma, Fibrillary,Astrocytoma, Gemistocytic,Astrocytoma, Intracranial,Astrocytoma, Juvenile Pilocytic,Astrocytoma, Pilocytic,Astrocytomas,Astrocytomas, Grade III,Astrogliomas,Cerebral Astrocytoma, Childhood,Cerebral Astrocytomas,Childhood Cerebral Astrocytomas,Fibrillary Astrocytomas,Gemistocytic Astrocytomas,Gliomas, Astrocytic,Grade I Astrocytoma,Grade I Astrocytomas,Grade II Astrocytoma,Grade II Astrocytomas,Grade III Astrocytoma,Grade III Astrocytomas,Intracranial Astrocytomas,Juvenile Pilocytic Astrocytomas,Mixed Oligoastrocytoma,Mixed Oligoastrocytomas,Pilocytic Astrocytoma, Juvenile,Pilocytic Astrocytomas,Pleomorphic Xanthoastrocytoma,Protoplasmic Astrocytoma,Protoplasmic Astrocytomas,Xanthoastrocytoma, Pleomorphic

Related Publications

Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
January 1994, Growth factors (Chur, Switzerland),
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
December 1993, Developmental biology,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
January 1991, Annals of the New York Academy of Sciences,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
October 1993, Cancer immunology, immunotherapy : CII,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
August 2002, Biological psychiatry,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
January 1995, Nutrition (Burbank, Los Angeles County, Calif.),
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
August 1991, Cancer cells (Cold Spring Harbor, N.Y. : 1989),
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
January 2005, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
September 1991, Japanese journal of cancer research : Gann,
Shinji Fukui, and Hiroshi Nawashiro, and Naoki Otani, and Hidetoshi Ooigawa, and Namiko Nomura, and Akiko Yano, and Takahito Miyazawa, and Akira Ohnuki, and Nobusuke Tsuzuki, and Hiroshi Katoh, and Shoichiro Ishihara, and Katsuji Shima
October 1994, In vitro cellular & developmental biology. Animal,
Copied contents to your clipboard!